Filana Therapeutics Inc (FLNA)

[ranchhand71]

Old wall street broker adage "buy the rumor. sell the news"
The stock had run ahead of itself the past month. After all, the news was fundamentally great regarding progress and key benchmarks.

IMHO -The big kahuna however will be the 12 month readouts in late September (?). If the pills continue to delay dementia progress and show any signs of memory recovery than stock could explode to the upside. SAVA has $4.4 billion market cap today with no FDA approval and no revenues. Biogen and Lilly added $10-20 billion market cap when announcing their AZ treatments with dementia delay BUT no claims of memory benefit.

"IF" the little two pills a day have good readouts after 12 months stock goes ballistic. After all, two pills is a lot more attractive to global patients than a once a month drive to a one hour Biogen infusion at an infusion center with an infusion nurse and then the need to get rid of all the infusion disposable materials.

Just one shareholder opinion. Would love to buy more back on the $80s for possible run to $300?